State Street Corp Celcuity Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Celcuity Inc. stock. As of the latest transaction made, State Street Corp holds 1,107,415 shares of CELC stock, worth $13.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,107,415

Previous 439,097 152.2%

Holding current value

$13.8 Million

Previous $7.19 Million 129.57%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$13.98 - $19.15 $9.34 Million - $12.8 Million	668,318 Added 152.2%	1,107,415 $16.5 Million
Q2 2024 Aug 14, 2024	BUY	$14.1 - $20.78 $1.45 Million - $2.13 Million	102,557 Added 30.47%	439,097 $7.19 Million
Q1 2024 May 15, 2024	BUY	$13.74 - $21.6 $547,992 - $861,472	39,883 Added 13.44%	336,540 $7.27 Million
Q4 2023 Feb 14, 2024	BUY	$8.7 - $15.02 $184,727 - $318,919	21,233 Added 7.71%	296,657 $4.32 Million
Q3 2023 Nov 14, 2023	BUY	$8.96 - $10.75 $121,175 - $145,383	13,524 Added 5.16%	275,424 $2.52 Million
Q2 2023 Aug 14, 2023	BUY	$9.39 - $12.18 $2.16 Million - $2.81 Million	230,520 Added 734.61%	261,900 $2.88 Million
Q2 2022 Aug 15, 2022	SELL	$5.35 - $10.11 $628,207 - $1.19 Million	-117,422 Reduced 78.91%	31,380 $286,000
Q1 2022 May 16, 2022	BUY	$7.93 - $13.33 $35,415 - $59,531	4,466 Added 3.09%	148,802 $1.39 Million
Q4 2021 Feb 14, 2022	BUY	$11.96 - $19.35 $72,381 - $117,106	6,052 Added 4.38%	144,336 $1.9 Million
Q3 2021 Nov 15, 2021	BUY	$17.35 - $24.87 $156,757 - $224,700	9,035 Added 6.99%	138,284 $2.49 Million
Q2 2021 Aug 16, 2021	BUY	$14.25 - $30.93 $1.84 Million - $4 Million	129,249 New	129,249 $3.1 Million
Q2 2020 Aug 14, 2020	SELL	$4.42 - $11.04 $396,283 - $989,813	-89,657 Closed	0 $0
Q1 2020 May 11, 2020	BUY	$5.79 - $11.78 $519,114 - $1.06 Million	89,657 New	89,657 $583,000

Others Institutions Holding CELC

# of Institutions

107

Shares Held

30.3M

Call Options Held

30.8K

Put Options Held

152K

View Full List

About Celcuity Inc.

Ticker CELC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,941,300
Market Cap $186M
Description
Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...

More about CELC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Celcuity Inc. Transaction History